Evaxion Biotech A/S ADR EVAX 深 滬
已收盤 10-10 16:00:00 美东时间
5.90
-0.530
-8.24%
華盛通- 最 高6.55
- 今 開6.53
- 成交量 45.43万股
- 最 低 5.81
- 昨 收 6.43
- 總市值 3726.79万
- 52周最高 15.50
- 市盈率 靜 --
- 換手率 0.01%
- 52周最低 1.20
- 委 比 68.12%
- 總股本 631.66万
- 歷史最高 1252.00
- 量 比 0.37
- 振 幅 11.51%
- 歷史最低 4.025
- 每 手 1
- 風險率 3.41%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Evaxion Unveils Automated Vaccine Design Module
Evaxion Biotech ( ($EVAX) ) just unveiled an update. On October 8, 2025, Evaxio...
10-08 20:27
Evaxion expands AI-Immunology™ platform with automated vaccine design module
Evaxion launches an AI-powered automated vaccine design module improving target discovery and vaccine design, reducing time and resources. The new AI-Immunology™ module enhances vaccine quality and efficiency, applicable to both new and existing vaccines. Evaxion will present results at the World Vaccine Congress Europe in Amsterdam on October 15, 2025.
10-08 12:12
Evaxion to present new biomarker data for AI-designed personalized cancer vaccine EVX-01 at the SITC 2025 Annual Meeting
Evaxion A/S will present new biomarker and immune data from its ongoing phase 2 trial with EVX-01 at the SITC 2025 Annual Meeting. The two-year clinical efficacy data from the trial will also be presented at the ESMO 2025 congress on October 17, 2025. EVX-01, a personalized cancer vaccine, is being evaluated for advanced melanoma and has shown promising results with 69% and 67% Overall Response Rates. The presentation at SITC will focus on immune...
10-03 13:00
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of their outstanding shares is at $165.6 million.
09-27 05:06
美股大行评级 | 星展银行上调百度评级至"买入"，目标价177美元；多家机构上调Guardant Health(GH)目标价最高至80美元
今日重点评级关注：Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12美元升至12.5美元；Oppenheimer：维持Immuneering"跑赢大市"评级，目标价从21美元升至30美元
09-26 09:45
Evaxion Out-Licenses Vaccine Candidate EVX-B3 to MSD
Evaxion Biotech ( ($EVAX) ) just unveiled an announcement. On September 25, 202...
09-25 19:47
Market-Moving News for September 25th
OPEN: 11% | Opendoor shares are trading higher after Jane Street Group disclosed in a 13G filing that it holds a 5.9% stake in the company. SPRC: 86% | SciSparc shares are trading higher after the company
09-25 19:24
Evaxion shares are trading higher after the company out-licensed its EVX-B3 vaccine candidate to MSD for a $7.5 million cash payment, up to $592 million in milestones and royalties on sales.
Evaxion shares are trading higher after the company out-licensed its EVX-B3 vac...
09-25 19:05
Evaxion Announces Conference Participation for H2 2025
Evaxion Biotech ( ($EVAX) ) has shared an announcement. On August 27, 2025, Eva...
08-27 20:46
Evaxion to present at several conferences during the second half of 2025
Evaxion A/S will present data and updates at numerous scientific and investor conferences across the US, Europe, and Asia in the second half of 2025. The company plans to engage with stakeholders, including potential partners, and share insights on its AI-Immunology platform and personalized cancer vaccine EVX-01. Key events include the ESMO Congress in October, where two-year clinical data for EVX-01 will be presented. Evaxion aims to strengthen...
08-27 12:00
